BRD4 and atherosclerosis: In addition, siBRD4 and BRD4 inhibitors, such as JQ-1 and I-BET762, could protect the cells against LPS-induced senescence, indicating that BRD4 is a potential drug target for atherosclerosis and aging-related diseases (Figure 8).